- Home
- PSTV vs EKSO Comparison
PSTV vs EKSO Comparison
Compare PSTV & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSTV | EKSO |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4M | 37.9M |
| IPO Year | 2016 | 2012 |
Fundamental Metrics
Financial Performance| Metric | PSTV | EKSO |
|---|---|---|
| Price | $0.25 | $11.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $6.75 | ★ $9.50 |
| AVG Volume (30 Days) | ★ 3.9M | 119.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.61 | 41.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,213,000.00 | N/A |
| Revenue This Year | N/A | $81.23 |
| Revenue Next Year | $46.30 | $7.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $0.23 |
| 52 Week High | $2.08 | $13.50 |
Technical Indicators
Market Signals| Indicator | PSTV | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 37.09 | 57.72 |
| Support Level | $0.21 | $9.18 |
| Resistance Level | $0.32 | $12.99 |
| Average True Range (ATR) | 0.03 | 0.96 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 6.51 | 52.07 |
Price Performance
Historical ComparisonAbout PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.